INCI Names vs Marketing Names: Why Cosmetic Labels Get Rejected (and How to Fix It)
The top cause of cosmetic ingredient-label rejections is writing the marketing name instead of the INCI name. A practitioner breakdown of the swaps that get flagged — and how to catch them before printing.
Quick answer
The number one cause of ingredient-label rejections in K-beauty isn't a banned ingredient — it's writing the marketing name instead of the INCI name. "Vitamin C," "Ceramide," and "Rice extract" are how shoppers and marketers talk; regulators and marketplaces expect the standardized INCI name (Ascorbic Acid, Ceramide NP, Oryza Sativa-based names). Get this wrong and the label is rejected — most often in the US — forcing an ingredient re-map and a label reprint. As an independent K-beauty manufacturing advisor who has run 300+ SKUs through Korean factories, here is where this goes wrong and how to catch it before you print.
Marketing name is not the INCI name
INCI (International Nomenclature of Cosmetic Ingredients) is the standardized naming system that regulators and marketplaces read your ingredient list in. The trap is simple: the name a customer recognizes is frequently not the INCI name. Founders write the label the way they market the product — "Vitamin C serum," "Ceramide cream" — and put those consumer-facing words on the ingredient list. Your manufacturer gives you the correct INCI on the spec sheet; the error is using the marketing name in its place.
The mismatches that get flagged most
From the production side, these are the swaps that come up again and again — vitamins, ceramides, and rice are ones I have repeatedly seen flagged, most often in the US market:
| Marketing name | INCI name (verify with your spec sheet) |
|---|---|
| Vitamin C | Ascorbic Acid — or a derivative (Sodium Ascorbyl Phosphate, Ascorbyl Glucoside, 3-O-Ethyl Ascorbic Acid) |
| Vitamin B3 | Niacinamide |
| Vitamin B5 / Pro-Vitamin B5 | Panthenol |
| Vitamin E | Tocopherol (or Tocopheryl Acetate) |
| Vitamin A / Retinol | Retinol (or a derivative such as Retinyl Palmitate) |
| Ceramide | Ceramide NP / AP / EOP (the number matters) |
| Rice extract | An Oryza Sativa (rice)-based INCI name |
The pattern: a vitamin or a hero ingredient gets written as its benefit name, not its chemical name. The fix is to map every line on your label back to the INCI on the manufacturer's spec sheet.
Where the marketing name actually breaks
Using the marketing name doesn't fail quietly at your desk — it fails at the gate, after you've printed. The typical chain: you print the label and carton with "Vitamin C," submit for clearance or a marketplace listing, and the ingredient list is rejected because the name isn't a recognized INCI. Now you re-map every affected ingredient, reprint labels and cartons, and resubmit — losing the print run and weeks of timeline. This shows up most often in the US, but the underlying rule — ingredient lists must use INCI — is broad.
One label is not enough: rules differ by country
Even a correct INCI list isn't the finish line. Which ingredients are allowed, and at what maximum concentration, differs by country. An ingredient and level that's fine in one market can be restricted or capped in another. So a label that clears the US may still need adjustment for the EU, and vice versa. For a brand selling into multiple markets, this isn't a one-time check — it needs ongoing monitoring, because the allowed-ingredient and concentration rules change over time.
An INCI checklist before you print
- Map every ingredient to its INCI — take the manufacturer's spec sheet as the source of truth, not the marketing copy.
- Watch the hero ingredients — vitamins, ceramides, and botanical/rice extracts are the most common marketing-name swaps.
- Confirm derivative names — "Vitamin C" can be several different INCI names depending on the actual raw material used.
- Check order and thresholds — ingredient order and any concentration-based rules must match the market you're filing in.
- Verify per market — confirm allowed ingredients and limits for each country you sell into, not just your home market.
- Monitor over time — set up a way to catch rule changes for the markets you're already in.
Why an independent review helps
A manufacturer provides the correct INCI on the spec sheet, but it's the brand that writes the final label — and a first-time brand often doesn't know that "Vitamin C" isn't a valid ingredient name, or that a level fine at home is capped abroad. An independent advisor isn't paid to place you into production, so the review is on your side: catching the marketing-name swaps and the per-market limits before the label goes to print. The point isn't to slow your launch — it's to keep your print run from being rejected at the border.
Related reading: How to audit a Korean manufacturing quote, how much private label cosmetics actually cost, and the pre-production QC checklist.
Get a written label & INCI review
Ingredient names, order, and per-market limits are all connected — a label that reads fine can still be rejected at filing. Before you print, send your ingredient list and target markets, and get up to 3 connected questions answered in writing within 24 hours — $499.
Get a written label & INCI review — $499
FAQ
Why is my cosmetic ingredient list getting rejected?
The most common reason is using a marketing name (like "Vitamin C" or "Ceramide") instead of the standardized INCI name (such as Ascorbic Acid or Ceramide NP). Marketplaces and regulators read ingredient lists in INCI.
What is the INCI name for Vitamin C?
It depends on the raw material used: commonly Ascorbic Acid, or a derivative such as Sodium Ascorbyl Phosphate, Ascorbyl Glucoside, or 3-O-Ethyl Ascorbic Acid. Always confirm against your manufacturer's spec sheet.
Does a label that passes in the US work everywhere?
Not necessarily. Allowed ingredients and maximum concentrations differ by country, so a compliant US label may still need changes for other markets — and the rules change over time.
When should I check INCI names?
Before printing labels and cartons. Re-mapping after print means reprinting labels and cartons and resubmitting, which costs the print run and weeks of delay.
Have a question like this?
Get a written answer specific to your situation — from someone inside Korean manufacturing.
Get a Written Answer →Stuck on something similar? Written answer in 12hrs.
Get a Written Answer →